Use of the insulin pump in treat cystic fibrosis related diabetes

Journal of Cystic Fibrosis

Volumn 8, Issue 3, 2009, Pages 174-178

  Hardin, Dana S ^a,b   Rice, Julie ^a,b   Rice, Mark ^a,b   Rosenblatt, Randall ^c  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis related diabetes; Hepatic glucose production; Insulin pump

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; LEUCINE; STABLE ISOTOPE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; BOLUS INJECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET RESTRICTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; LEAN BODY WEIGHT; MALE; POSTPRANDIAL STATE; PROTEIN DEGRADATION; PROTEIN METABOLISM;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PROTEINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349256751     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2008.12.001     Document Type: Article

References (27)

1. Moran A., Hardin D.S., Rodman D., Allen H.F., Beall R.J., Borowitz D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 45 (1999) 61-73
2. Moran A., Diem P., Klein D., Levitt M.D., and Robertson R.P. Pancreatic endocrine function in cystic fibrosis. J Pediatr 118 (1991) 715-723
3. Hardin D.S., LeBlanc A., Lukenbaugh S., and Seilheimer D.K. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 6 (1997) 948-956
4. Cobry E., Chase H.P., Burdick P., McFann K., Yetzer H., and Scrimgeour L. Use of CoZmonitor in youth with type 1 diabetes. Pediatr Diabetes 9 2 (Apr 2008) 148-151
5. Hardin D.S., LeBlanc A., Para L., and Seilheimer D.K. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 48 (1999) 1082-1087
6. Borowitz D., Baker R.D., and Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. Ped Gastr Nutr 35 (2002) 246-259
7. Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis. Curr Opin Pulm Med 2 (1996) 457-461
8. Scrimgeour L., Cobry E., McFann K., Burdick P., Weimer C., Slover R., et al. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 9 5 (Oct 2007) 421-428
9. Wainstein J., Metzger M., Boaz M., Minuchin O., Cohen Y., Yaffe A., et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 22 8 (Aug 2005) 1037-1046
10. Chase H.P., Horner B., McFann K., Yetzer H., Gaston J., Banion C., et al. The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care 29 5 (May 2006) 1012-1015
11. Sulli N., Betasi S., Zulo S., and Shashaj B. Use of continuous subcutaneous insulin infusion inpatients with cystic fibrosis related diabetes: three case reports. J Cystic Fibrosis 6 (2007) 237-240
12. Finkelstein S.M., Wielinski C.L., Elliott G.R., Warwick W.J., Barbosa J., Wu S., et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 112 (1988) 373-377
13. Milla C.E., Warwick W.J., and Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 891-895
14. Holt T.L., Ward L.C., Francis P.J., Isles A., Cooksley W.G.E., and Shepherd R.W. Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease. Am J Clin Nutr 41 (1985) 1061-1066
15. Levy L.D., Durie P.R., Pencharz P.B., and Corey M.L. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 107 (1985) 225-230
16. Hardin D.S., LeBlanc A., Lukenbaugh S., Para L., and Seilheimer D.K. Increased rates of proteolysis associated with insulin resistance in cystic fibrosis. Pediatr I01 (1998) 948-956
17. Gougeon R., Pencharz P.B., and Marliss E.B. Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43 (1994) 318-328
18. Moran A., Milla C., Ducret R., and Nair K.S. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 50 6 (2001) 1336-1343
19. Hasselgren P., and Fischer J.E. Regulation by insulin of muscle protein metabolism during sepsis and other catabolic conditions. Nutrition 8 (1992) 434-439
20. Kien C.L., Horswill C.A., Zipf W.B., and McCoy K.S. Elevated hepatic glucose output (HGO) in children with cystic fibrosis (CF): an early sign of defective insulin secretion/action?. Pediatr Res 35 (1994) 1208
21. Haymond M.W., and Sunehag A.L. The reciprocal pool model for the measurement of gluconeogenesis by use of [U-(13)C]glucose. Am J Physiol Endocrinol Metab 278 1 (2000) E140-5
22. Hardin D.S., and Moran A. Diabetes mellitus in cystic fibrosis. Pediatr Clin North Am 28 4 (2000) 787-800
23. Milla C.E., Billings J., and Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28 9 (Sep 2005) 2141-2144
24. Lanng S., Thorsteinsson B., Nerup J., and Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr Scand 83 (1994) 849-853
25. Rafii M., Chapman K., Stewart C., Kelly E., Hanna A., Wilson D.C., et al. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 81 2 (Feb 2005) 421-426
26. Miller M., Ward L., Thomas B.J., Cooksley W.G.E., and Shepherd R.W. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis. Am J Clin Nutr 36 (1982) 492-499
27. Pelekanos J.T., Holt T.L., Ward L.C., Cleghorn G.J., and Shepherd R.W. Protein Turnover in malnourished patients with cystic fibrosis: effects of elemental and nonelemental nutritional supplements. 10 ed. (1990) 339-343